ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 750,25
0,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) Actualités

BDSX

Biodesix (BDSX)

Biodesix Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BDSX
DateHeureSourceTitreSymboleSociété
28/05/202412h00Business WireBiodesix to Participate in Two Investor Conferences in JuneNASDAQ:BDSXBiodesix Inc
24/05/202422h11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BDSXBiodesix Inc
24/05/202401h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
24/05/202401h09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDSXBiodesix Inc
21/05/202412h00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
09/05/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202422h01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202412h00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202412h00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202423h00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202413h17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202411h00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202412h11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
01/03/202412h00Business WireBiodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business HighlightsNASDAQ:BDSXBiodesix Inc
26/02/202412h00Business WireBiodesix to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
16/02/202412h00Business WireBiodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024NASDAQ:BDSXBiodesix Inc
02/02/202422h09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BDSXBiodesix Inc
14/11/202312h00Business WireBiodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw MethodNASDAQ:BDSXBiodesix Inc
09/11/202312h00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in NovemberNASDAQ:BDSXBiodesix Inc
07/11/202322h01Business Wire Biodesix Announces Third Quarter 2023 Results and HighlightsNASDAQ:BDSXBiodesix Inc
24/10/202312h00Business WireBiodesix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:BDSXBiodesix Inc
03/10/202312h00Business WireBiodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual MeetingNASDAQ:BDSXBiodesix Inc
07/09/202312h00Business WireBiodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung CancerNASDAQ:BDSXBiodesix Inc
05/09/202312h00Business WireBiodesix to Participate in Two Upcoming Investor Conferences in SeptemberNASDAQ:BDSXBiodesix Inc
22/08/202312h00Business WireBiodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing CancerNASDAQ:BDSXBiodesix Inc
07/08/202322h01Business WireBiodesix Announces Second Quarter 2023 Results and HighlightsNASDAQ:BDSXBiodesix Inc
01/08/202312h00Business WireBiodesix to Participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:BDSXBiodesix Inc
26/07/202322h06Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:BDSXBiodesix Inc
 Showing the most relevant articles for your search:NASDAQ:BDSX

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
BEL20
Bel 20
EU
BN
Danone
EU
HO
Thales
EU
VIV
Vivendi
NYSE
NKE
Nike
EU
DG
Vinci
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
NVDA
NVIDIA
EU
ML
Michelin
EU
RI
Pernod Ricard
EU
VK
Vallourec
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés